A systematic review of reference pricing: Implications for us prescription drug spending

Joy Li Yueh Lee, Michael A. Fischer, William H. Shrank, Jennifer M. Polinski, Niteesh K. Choudhry

Research output: Contribution to journalReview article

32 Scopus citations

Abstract

Given rising pharmaceutical expenditures and the widespread use of reference pricing as a costcontainment instrument abroad, we systematically reviewed the evidence evaluating reference pricing policies. We performed a structured electronic search of peer-reviewed journals for studies published before that reported on the effects of reference pricing policies on medication use, payer and patient spending, and resource consumption. Our search yielded 16 studies describing 9 reference-pricing policies from 6 countries. Reference-pricing policies led to decreases in drug prices and increases in utilization of targeted medications, while also reducing payer and patient expenditures. In addition, these policies did not lead to increased use of medical services, such as physician office visits and hospitalization. These results suggest that reference pricing may be an attractive policy strategy for the US healthcare system.

Original languageEnglish (US)
Pages (from-to)e429-e437
JournalAmerican Journal of Managed Care
Volume18
Issue number11
StatePublished - Nov 1 2012
Externally publishedYes

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'A systematic review of reference pricing: Implications for us prescription drug spending'. Together they form a unique fingerprint.

  • Cite this

    Lee, J. L. Y., Fischer, M. A., Shrank, W. H., Polinski, J. M., & Choudhry, N. K. (2012). A systematic review of reference pricing: Implications for us prescription drug spending. American Journal of Managed Care, 18(11), e429-e437.